At a glance
ClinicalIndex Comparison RecordN/ACompleted· 775 enrolled
Drug / intervention
Peripheral stentingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
In Brief
A clinical study evaluating Peripheral stenting for Arterial Occlusive Diseases and 3 related conditions. Completed, enrolled 775 participants across 60 sites in 10 countries.
Detailed Summary
The EMINENT study is a prospective, multi-center study evaluating the effectiveness of the ELUVIA stent versus Self-Expanding Bare Nitinol Stents in the treatment of lesions in the femoropopliteal arteries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 2016
Enrollment StartOct 2016
Primary CompletionJul 2021
Study CompletionNov 2023
TodayJul 2026
First PostedOct 3, 2016
Enrollment StartOct 25, 2016
Primary CompletionJul 2, 2021
Study CompletionNov 6, 2023
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 9.7 years ago
Interventions
Peripheral stentingdevice
stent implantation during the index procedure